Notably, this bacterium has been associated with resistance to cetuximab—an anti-EGFR monoclonal antibody—by activating the PI3K/AKT and JAK/STAT3 signaling pathways, resulting in elevated half-maximal inhibitory concentrations (IC50) in infected tumor cells [135]. Here, AKT1 is linked to neoplasm.